1. Naurois JD, Novitzky-Basso I, Gill MJ, Martil M, Cullen MH, et al. Management of febrile neutropenia: ESMO clinical practice guidelines. Annals of Oncology .2010. 21:v252-256.
2. Lyman GH. Guidelines of the National Comprehensive Cancer Center Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence. J Natl Compr Cancer Netw. 2005;3:557-571
3. Kuderer NM, Dale DC, Crawford J, et al. Mortality, Morbidity and Cost Associated with Febrile Neutropenia in Adult Cancer Patient. Cancer. 2006;106:2258-66.
4. Crawford J, Dale DC, Lyman GH. Chemoterapy-induced neutropenia: Risks, Consequences and New direction for Its Management. Cancer.2004:100(2):228-237.
5. Lyman GH, Kuderer NM, Balducci L. Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients. Curr Opin Hematol. 2002;9:207–214
6. Patel, K. Febrile Neutropenia. JAMA oncol. 2017;3(12):1751
7. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730 –751.
8. Klastersky J, Paesmans M.The multinational Association for Supportive Care in Cancer (MASSC) index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer. 2013;21(5):1487-95.
9. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142: 979–995. [Erratum, Ann Intern Med 2006; 144:704].
10. J. Klastersky, J.D.Naurois, K.Rolston, B.Rapoport, et al. Management of febrile neutropenia: ESMO clinical practice guidelines. Annals of oncology. 2016;27(supplement 5):v111-v118.
11. Elting LS, Lu C, Escalante CP et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 2008; 26: 606–611.
12. Montassier E, Batard E, Gastinne T et al. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 2013; 32: 841–850
13. Raad I, Kassar R, Ghannam D et al. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis 2009; 49: 1187–1194.